Abstracts Archive - Page 990 of 2607 - ACR Meeting Abstracts

Abstract Number: 748 • 2019 ACR/ARP Annual Meeting
Takayasu Arteritis and Sacroiliitis: A Case Control Study in 28 Patients of a Single Italian Center
Paola Toniati¹, Francesca Regola ¹, Franco Franceschini ¹, Giovanni Bosio ² and Angela Tincani ³, ¹Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, Brescia, Italy, ²Nuclear Medicine Unit, ASST Spedali Civili of Brescia, Brescia, Italy, Brescia, Italy, ³Rheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy, Brescia, Italy
Background/Purpose: A lot of clinical case descriptions about spondyloarthropathy in TAK patients were reported. Recently, a paper about an increased incidence of spondyloarthropathy in TAK…
Abstract Number: 749 • 2019 ACR/ARP Annual Meeting
Childhood Takayasu Arteritis: Characteristics and Outcomes of a Mexican Cohort
Grissell Alejandra Valero-Gaona¹, Enrique Faugier-Fuentes ² and Angélica Vargas Guerrero ³, ¹Departamento de Reumatología, Instituto Nacional de Cardiología "Ignacio Chávez", Ecatepec, Distrito Federal, Mexico, ²Department of Rheumatology, Hospital Infantil de México Federico Gómez, Mexico City, Mexico, ³Departamento de Reumatología del Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
Background/Purpose: Takayasu arteritis (TA) is a large vessel vasculitis that affects aorta and its main branches. Despite being the third most common vasculitis in childhood,…
Abstract Number: 750 • 2019 ACR/ARP Annual Meeting
Extravascular Inflammatory Manifestations of Takayasu Arteritis in a Monocentric Cohort
Elena Baldissera¹, Alessandro Tomelleri ¹, Silvia Sartorelli ², Corrado Campochiaro ³ and Lorenzo Dagna ¹, ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases. IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University., Milan, Italy, ²Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy, ³Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy
Background/Purpose: Takayasu arteritis (TAK) is an inflammatory disease which primarily affects large vessels. However, as a systemic disease, the spectrum of its manifestations is not…
Abstract Number: 751 • 2019 ACR/ARP Annual Meeting
Pregnancy Outcome in Patients with Takayasu Arteritis: The Results of Turkish Takayasu Study Group
Nilufer Alpay-Kanitez ¹, Sema Kaymaz-Tahra ², Ayten Yazici ³, Ayse Cefle ⁴, Mete Kara ⁵, Handan Yarkan-Tugsal ⁶, Onay Gercik ⁷, Servet Akar ⁸, Fatos Onen ⁹, Kenan Aksu ¹⁰, Gokhan Keser ⁵, Cemal Bes ¹¹, Sevil Kamalı ¹², Fatma Alibaz-Oner ¹³ and Haner Direskeneli¹⁴, ¹Koc University School of Medicine, Division of Rheumatology, İstanbul, Turkey, ²Marmara University School of Medicine, Division of Rheumatology, Istanbul, Istanbul, Turkey, ³Kocaeli University, Faculty of Medicine, Division of Rheumatology, Kocaeli, Kocaeli, Turkey, ⁴Kocaeli University, Faculty of Medicine, Division of Rheumatology, Kocaeli, Turkey, ⁵Ege University School of Medicine, Division of Rheumatology, Izmir, Turkey, ⁶Dokuz Eylul University School of Medicine, Division of Rheumatology, Izmir, Turkey, ⁷Izmir Katip Celebi University, Faculty of Medicine, Division of Rheumatology, Izmir, Turkey, ⁸Izmir Katip Celebi University, Faculty of Medicine, Division of Rheumatology, İzmir, Turkey, ⁹Dokuz Eylul University School of Medicine, Division of Rheumatology, İzmir, Turkey, ¹⁰Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, ¹¹University of Medical Sciences, İstanbul, Turkey, ¹²Private office, İstanbul, Turkey, ¹³Marmara University Faculty of Medicine,Department of Rheumatology,Istanbul,Turkey, Istanbul, Turkey, ¹⁴Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey
Background/Purpose: Takayasu's arteritis (TAK) is a large vessel vasculitis of the young women in their reproductive age. According to our previous report from single center…
Abstract Number: 752 • 2019 ACR/ARP Annual Meeting
Drug Retention and Discontinuation Reasons Between Seven Biologics in Patients with Takayasu Arteritis
Corrado Campochiaro¹, Alessandro Tomelleri ², Silvia Sartorelli ³, Giulio Cavalli ², De Luca Giacomo ⁴, Elena Baldissera ² and Lorenzo Dagna ², ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy, ²Unit of Immunology, Rheumatology, Allergy and Rare Diseases. IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University., Milan, Italy, ³Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy, ⁴Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy., Milan, Italy
Background/Purpose: Takayasu's arteritis (TA) is a large vessel vasculitis affecting mainly young women. Biologic agents are currently use to treat refractory TA patients but no…
Abstract Number: 753 • 2019 ACR/ARP Annual Meeting
Initial Clinical Presentation Is Associated with Outcome in Takayasu’s Arteritis
Kaitlin Quinn¹, K Bates Gribbons ², Elaine Novakovich ³ and Peter C. Grayson ⁴, ¹Georgetown University Hospital/National Institutes of Health, Washington, DC, ²National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ³National Institutes of Health, Bethesda, MD, ⁴National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health, Bethesda, MD, Bethesda, MD
Background/Purpose: The natural history of Takayasu’s arteritis (TAK) remains poorly characterized. A “triphasic” pattern of disease has been proposed where constitutional symptoms precede vascular inflammation…
Abstract Number: 754 • 2019 ACR/ARP Annual Meeting
Dynamic Distribution and Phenotype Shift from M1 to M2 of Macrophages in Vascular Lesions of Naïve and Treated Patients with Takayasu Arteritis
Xiufang Kong¹, Ming Xu ², Xiaomeng Cui ², Lingying Ma ², Huiyong Chen ³, Lili Ma ² and Lindi Jiang ², ¹University of Michigan & Fudan University, Ann Arbor, MI, ²Zhongshan Hospital, Fudan University, Shanghai, China (People's Republic), ³Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai
Background/Purpose: Takayasu arteritis (TA) is a chronic inflammatory disease characterized by arterial vascular fibrosis. Type I (M1) and type II (M2) macrophages play very important…
Abstract Number: 755 • 2019 ACR/ARP Annual Meeting
A Novel Diagnostic Algorithm for Polymyalgia Rheumatica Using Three Musculoskeletal Sites on Whole Body PET/CT
Claire Owen¹, Aurora Poon ¹, Victor Yang ¹, Chris McMaster ¹, Sze Ting Lee ¹, David Liew ¹, Jessica Leung ¹, Andrew Scott ¹ and Russell Buchanan ¹, ¹Austin Health, Heidelberg, Victoria, Australia
Background/Purpose: PMR is associated with a pattern of abnormal 18F-Fluorodeoxyglucose (18F-FDG) uptake on whole body PET/CT that is increasingly recognised to correlate anatomically with inflammation…
Abstract Number: 756 • 2019 ACR/ARP Annual Meeting
A Volar Pattern of 18F-Fluorodeoxyglucose Uptake at the Hand on Whole Body PET/CT Predicts Glucocorticoid-Responsive Disease in Polymyalgia Rheumatica
Claire Owen¹, Aurora Poon ¹, Sze Ting Lee ¹, Chris McMaster ¹, Jessica Leung ¹, David Liew ¹, Andrew Scott ¹ and Russell Buchanan ¹, ¹Austin Health, Heidelberg, Victoria, Australia
Background/Purpose: Almost half of all patients diagnosed with PMR require a protracted duration of glucocorticoid therapy due to relapsing disease.(1) On whole body PET/CT, PMR…
Abstract Number: 757 • 2019 ACR/ARP Annual Meeting
Long-term Clinical Course and Outcomes of 2013 Patients with Takayasu Arteritis
Hajime Yoshifuji¹, Haruhito Uchida ², Yoshikazu Nakaoka ³, Takahiko Sugihara ⁴, Mitsuaki Isobe ⁵ and Masayoshi Harigai ⁶, ¹Kyoto University, Kyoto, Japan, ²Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, ³National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan, ⁴Tokyo Medical and Dental University, Tokyo, Japan, ⁵Sakakibara Heart Institute, Tokyo, Japan, ⁶Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan
Background/Purpose: Takayasu arteritis (TAK) occurs at a young age and has a long-term clinical course. Progression of arterial stenosis or dilatation leads to organ dysfunction.…
Abstract Number: 758 • 2019 ACR/ARP Annual Meeting
Interleukin-6 May Predict Disease Relapse During Long-term Follow-up in Takayasu’s Arteritis in a Han Chinese Population
Ying Sun¹, Kong Xiufang ² and Lindi Jiang ³, ¹Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China, Shanghai, ²Zhongshan Hospital Fudan University, ShangHai, China (People's Republic), ³Zhongshan hospital, Fudan University, Shanghai, China (People's Republic)
Background/Purpose: To evaluate the role of interleukin-6 (IL-6) in predictinglong-term disease prognosis for Takayasu’s arteritis (TA).Methods: Thirty-one patients diagnosed with TA between January 2012 and…
Abstract Number: 759 • 2019 ACR/ARP Annual Meeting
Polymyalgia Rheumatica Patients with and Without Elevated Baseline Acute Phase Reactants: Distinct Subgroups of Polymyalgia Rheumatica?
Diane Marsman¹, Aatke van der Maas ¹, Alfons den Broeder ¹, Nathan den Broeder ¹, Nadine Boers ² and Frank van den Hoogen ¹, ¹Sint Maartenskliniek, Nijmegen, Netherlands, ²Sint Maartenskliniek, Nijmegen
Background/Purpose: Systemic signs of inflammation such as raised CRP or ESR are a classical feature of PMR, but some patients present with normal acute phase…
Abstract Number: 760 • 2019 ACR/ARP Annual Meeting
Prescribing Methotrexate in Polymyalgia Rheumatica: A Missed Opportunity?
Diane Marsman¹, Aatke van der Maas ¹, Nathan den Broeder ¹, Thomas Bolhuis ¹, Nadine Boers ², Alfons den Broeder ¹ and Frank van den Hoogen ¹, ¹Sint Maartenskliniek, Nijmegen, Netherlands, ²Sint Maartenskliniek, Nijmegen
Background/Purpose: Patients with polymyalgia rheumatica (PMR) and giant cell arthritis (GCA) constitute approximately 20% of diseases chronically treated with glucocorticoids (GC) with a daily dose…
Abstract Number: 761 • 2019 ACR/ARP Annual Meeting
Polymyalgia Rheumatica: Winter Is Coming
Diane Marsman¹, Aatke van der Maas ¹, Alfons den Broeder ¹, Frank van den Hoogen ¹, Nathan den Broeder ¹ and Nadine Boers ², ¹Sint Maartenskliniek, Nijmegen, Netherlands, ²Sint Maartenskliniek, Nijmegen
Background/Purpose: The cause for polymyalgia rheumatic (PMR) is currently unknown. Disease onset may be triggered by a combination of genetic predisposition and environmental factors such…
Abstract Number: 762 • 2019 ACR/ARP Annual Meeting
Are There Any Identifiable Triggers in Polymyalgia Rheumatica? A Matched-Control Study
Mayra Tobar Jaramillo¹, Victor Santos Andrade ², Marina Scolnik ³, Luciano Fernando Lo Giudice ⁴, John Jaramillo Gallego ⁵, Valeria Scaglioni ⁵ and Enrique Soriano ⁶, ¹Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, ²Rheumatology Section, Internal Medicine Service, Fundacion Valle de lili, Colombia, Cali, Valle del Cauca, Colombia, ³Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, ⁴Hospital Italiano de Buenos Aires, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, ⁵Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina, Ciudad Autónoma de Buenos Aires, Argentina, ⁶Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina., Buenos Aires, Buenos Aires, Argentina
Background/Purpose: As many other rheumatologic diseases, pathogenesis of Polymyalgia Rheumatica (PMR) isnot well understood. Genetic factors seem to play a role. Some studies have suggested…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].